College of Pharmacy, Pusan National University, Busan, Korea (South).
Amgen Inc., Thousand Oaks, CA, United States of America.
PLoS One. 2020 Jan 30;15(1):e0228472. doi: 10.1371/journal.pone.0228472. eCollection 2020.
It is important to achieve the low-density lipoprotein cholesterol (LDL-C) goal recommended by clinical guidelines in managing the risk of cardiovascular (CV) events, however, the current management of LDL-C in actual clinical settings is suboptimal. We examined the LDL-C level among patients with dyslipidemia against the 2015 Korean guidelines, the crude rates of CV events based on LDL-C goal achievement, and the factors associated with LDL-C goal achievement.
This was a retrospective cohort study using the National Health Insurance Service-National Health Screening Cohort (NHIS-HEALS) database from 2006 to 2013. Patients who had a health examination with LDL-C measurement between January 1, 2007, and December 31, 2011 were identified. Patients were required to have at least one diagnosis of dyslipidemia during the 1 year before the index date, defined as the first date of LDL-C measurement. The 2015 Korean guidelines were used to measure LDL-C goal achievement based on the CV risk level. Crude CV event rates were calculated for total and individual CV events as the number of events divided by person-years (PYs) during the follow-up period. CV events included acute coronary syndrome, ischemic stroke, peripheral artery disease, CV death, and all-cause death. Factors associated with LDL-C goal achievement were assessed using logistic regression.
In the NHIS-HEALS database, 69,942 patients met the eligibility criteria: 36.7%, 22.5%, 20.1%, and 20.6% were among the very high-, high-, moderate-, and low-risk groups for the CV events, respectively, as defined by the 2015 Korean guidelines. Approximately half of the patients with dyslipidemia (47.6%) achieved their recommended LDL-C goal, but the achievement rates were substantially different across CV risk levels (17.6%, 47.2%, 66.9%, and 82.4% for very high-, high-, moderate-, and low-risk groups, respectively; P<0.0001). The crude event rate of total CV events during the follow-up period in the LDL-C goal non-achievers was higher than that in the LDL-C goal achievers (24.35/100 PYs vs. 11.93/100 PYs; P<0.0001). LDL-C goal achievement was significantly associated with patient characteristics, including age, sex, body mass index, lipid-modifying therapy, and CV risk level.
In South Korea, LDL-C goal achievement among patients with very high or high CV risk was suboptimal. Patients who did not achieve the goal showed a higher rate of CV events during the follow-up period than patients who achieved the goal. LDL-C management strategies should be highlighted in dyslipidemia patients who are less likely to achieve the goal, such as female, overweight or obese patients, patients not adherent to statin, or patients with very high or high CV risk.
在管理心血管(CV)事件风险方面,达到临床指南推荐的低密度脂蛋白胆固醇(LDL-C)目标非常重要,但目前在实际临床环境中 LDL-C 的管理并不理想。我们检查了血脂异常患者的 LDL-C 水平与 2015 年韩国指南的对比,根据 LDL-C 目标实现情况的未校正 CV 事件发生率,以及与 LDL-C 目标实现相关的因素。
这是一项使用 2006 年至 2013 年国家健康保险服务-国家健康筛查队列(NHIS-HEALS)数据库的回顾性队列研究。确定了 2007 年 1 月 1 日至 2011 年 12 月 31 日之间进行 LDL-C 测量的健康检查患者。要求患者在指数日期之前的 1 年内至少有一次血脂异常诊断,定义为 LDL-C 测量的首次日期。根据 2015 年韩国指南,基于 CV 风险水平来衡量 LDL-C 目标的实现情况。未校正 CV 事件发生率根据随访期间的总 CV 事件和个体 CV 事件的数量除以人年(PY)进行计算。CV 事件包括急性冠脉综合征、缺血性卒、外周动脉疾病、CV 死亡和全因死亡。使用逻辑回归评估 LDL-C 目标实现的相关因素。
在 NHIS-HEALS 数据库中,有 69942 名患者符合入选标准:根据 2015 年韩国指南,分别有 36.7%、22.5%、20.1%和 20.6%的患者属于 CV 事件极高风险、高风险、中风险和低风险组。大约一半的血脂异常患者(47.6%)达到了推荐的 LDL-C 目标,但在 CV 风险水平方面,实现率差异很大(极高风险、高风险、中风险和低风险组分别为 17.6%、47.2%、66.9%和 82.4%;P<0.0001)。在 LDL-C 目标未达标患者的随访期间,总 CV 事件的未校正发生率高于 LDL-C 目标达标患者(24.35/100 PYs 与 11.93/100 PYs;P<0.0001)。LDL-C 目标的实现与患者特征显著相关,包括年龄、性别、体重指数、调脂治疗和 CV 风险水平。
在韩国,极高或高 CV 风险患者的 LDL-C 目标实现情况并不理想。与目标达标患者相比,未达标患者在随访期间的 CV 事件发生率更高。在不太可能实现目标的血脂异常患者中,如女性、超重或肥胖患者、不遵医嘱服用他汀类药物的患者或具有极高或高 CV 风险的患者,应强调 LDL-C 管理策略。